Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Halts Gardasil Lobbying Efforts Following Discussions With ACIP, AAP

Executive Summary

Merck decided to halt lobbying efforts for state legislation requiring vaccination with its human papilloma virus vaccine Gardasil for school entry following discussions with third party stakeholders, including CDC's Advisory Committee on Immunization Practices and the American Academy of Pediatrics, the company said

You may also be interested in...



HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?

The first approved HIV vaccine should be initially indicated for both adolescent and adult populations, but how and when to enroll adolescents in clinical trials is less straightforward, FDA's Pediatric Ethics Subcommittee determined at a June 9 meeting

HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?

The first approved HIV vaccine should be initially indicated for both adolescent and adult populations, but how and when to enroll adolescents in clinical trials is less straightforward, FDA's Pediatric Ethics Subcommittee determined at a June 9 meeting

NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination

Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue

Related Content

UsernamePublicRestriction

Register

PS048079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel